Koide Naohiko, Komatsu Daisuke, Hiraga Risako, Kitazawa Masato, Suzuki Akira, Miyagawa Shinichi
Department of Surgery, Shinshu University School of Medicine, Asahi, 3-1-1, Matsumoto, 390-8621, Japan.
Hepatogastroenterology. 2010 May-Jun;57(99-100):513-8.
BACKGROUND/AIMS: We historically investigated the clinicopathologic features of esophageal cancer associated with other primary cancers (OPC), and discussed differences between the last decade and the previous period.
A total of 359 patients with esophageal cancer treated between 1981 and 2006 were enrolled. They were divided into 2 groups; 213 patients between 1981 and 1996 (Group-A), and 146 patients between 1997 and 2006 (Group-B).
Between Group-A and Group-B, there was a significant difference in the frequency of OPC (15.5% vs. 32.2%, p < 0.001). Regarding the site of OPC, there was a significant difference in the frequency of head and neck cancers (p < 0.001). There was a significant difference in the frequency of metachronous OPC between Group-A and Group-B (5.6% vs. 18.5%, p < 0.001). Antecedent OPC was more frequently observed in Group-B than Group-A (3.3% vs. 11.0%, p < 0.01), and subsequent OPC was also more frequently observed in Group-B than Group-A (2.8% vs. 7.5%, p < 0.05). Although the 5-year survival rate after esophagectomy of the patients without OPC was better in Group-B than Group-A (31.5 % vs. 52.7 %; p < 0.01), there was no difference in that of the patients with OPC between Group-A and Group-B, (40.7% vs. 54.2%).
Metachronous as well as synchronous OPC in esophageal cancer patients were more frequent in the recent period than in the previous period. We should consider antecedent, synchronous, and subsequent OPC in esophageal cancer patients.
背景/目的:我们既往研究了与其他原发性癌症(OPC)相关的食管癌的临床病理特征,并讨论了过去十年与之前时期的差异。
纳入1981年至2006年间接受治疗的359例食管癌患者。他们被分为两组;1981年至1996年间的213例患者(A组),以及1997年至2006年间的146例患者(B组)。
A组和B组之间,OPC的发生率存在显著差异(15.5%对32.2%,p<0.001)。关于OPC的部位,头颈部癌症的发生率存在显著差异(p<0.001)。A组和B组之间异时性OPC的发生率存在显著差异(5.6%对18.5%,p<0.001)。B组比A组更频繁地观察到先行OPC(3.3%对11.0%,p<0.01),并且B组也比A组更频繁地观察到后续OPC(2.8%对7.5%,p<0.05)。虽然无OPC患者食管切除术后的5年生存率B组优于A组(31.5%对52.7%;p<0.01),但A组和B组有OPC患者的5年生存率没有差异(40.7%对54.2%)。
近期食管癌患者的异时性以及同时性OPC比之前时期更频繁。我们应该考虑食管癌患者的先行、同时性和后续OPC。